| Cat. No. |
Size |
Price |
Figures |
RP11119-0.5 mg
| 0.5 mg | $ 109.25 | MSDS: 20080922213556 (PDF) STRUCTURE:
 Zoom
References:
- Brandt I, et al. Dipeptidyl-peptidase IV converts intact B-type natriuretic peptide into its des-SerPro form. Clin. Chem. Jan 2006; 52(1): 82-87.
- Prontera C, et al. Comparison of a fully automated immunoassay with a point-of-care testing method for B-type natriuretic peptide. Clin. Chem. Jul 2005; 51(7): 1274-1276.
- Sengenes C, et al. Natriuretic peptide-dependent lipolysis in fat cells is a primate specificity. Am. J. Physiol. Regul. Integr. Comp. Physiol. Jul 2002; 283(1): R257-265.
|
|---|
| Full Name | | Brain Natriuretic Peptide (BNP) (1-32), human |
|
| Alias |
Brain Natriuretic Peptide(1-32), human |
Sequence (one-letter code) |
SPKMVQGSGCFGRKMDRISSSSGLGCKVLRRH (Disulfide bridge: 10-26) |
Sequence (three-letter code) | {SER}{PRO}{LYS}{MET}{VAL}{GLN}{GLY}{SER}{GLY}{CYS} {PHE}{GLY}{ARG}{LYS}{MET}{ASP}{ARG}{ILE}{SER}{SER} {SER}{SER}{GLY}{LEU}{GLY}{CYS}{LYS}{VAL}{LEU}{ARG} {ARG}{HIS} |
| Chemical Bridge | Disulfide bridge: Cys10-Cys26 |
|---|
| Description | Brain natriuretic peptide (type B natriuretic peptide, BNP) was originally isolated from brain, but is mainly produced in myoendocrine cells of the heart ventricles from which it is released into the circulatory ststem. BNP is involved in blood pressure control and cardiovascular homeostasis. |
|---|
| Solubility | The peptide is soluble in water. The contents of this vial have been accurately determined. Both the stopper and the vial have been siliconized. Do not attempt to weigh out a smaller portion of the contents. |
|---|
| Formula | C143H244N50O42S4 |
| M.W. | 3464.1 |
| Cas | 114471-18-0 |
|---|
| Purity | > 95% |
| Storage | Store the peptide at -20°C. |